CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 175 enrolled
Drug / intervention
Medical Chart Review +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04089488
NCT04089488N/ACompleted
CompareCT.gov

Prospective Observational Study of Site-Specific Incident and Prevalent Cases of Cancer in People Living With HIV/AIDS- in Latin America

AIDS Malignancy Consortium·observational·Posted Sep 13, 2019·Updated Sep 1, 2023

In Brief

An observational study evaluating Medical Chart Review and Survey Administration for HIV Infection and 3 related conditions. Completed, enrolled 175 participants across 4 sites in 3 countries.

Detailed Summary

This trial studies the frequency of incident and prevalent of cancer in people living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) at cancer centers in Latin America. By counting how many people living with HIV/AIDS have cancer at these specific centers, researchers may better understand how they are being treated and cared for. This may help researchers to understand what new studies may be helpful for those areas in the future.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infection, Human Immunodeficiency Virus 1 Positive, Malignant Neoplasm, Recurrent Malignant Neoplasm
CountriesArgentina, Brazil, Mexico
CollaboratorsNational Cancer Institute (NCI), The Emmes Company, LLC, University of Arkansas

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedSep 13, 2019
Enrollment StartJan 17, 2020
Primary CompletionOct 18, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.8 years ago

Interventions

Medical Chart Reviewother

Correlative studies

Survey Administrationother

Respond to surveys